ARM partners with researchers from University of Washington to develop chips for neural implants to help people with brain and spinal injuries
Chip design giant ARM has teamed up with US researchers on a project to develop chips that can be implanted in the human brain.
Context & Ripple Effects
ARM's tie-up with University of Washington researchers lands one year after Bryan Johnson launched Kernel, the USC-backed startup building implantable chips for neurological damage — evidence that brain-computer interfaces had moved from Musk-style moonshots to mainstream silicon players by mid-2017.
First-order effects
- ARM contributes its low-power chip design expertise directly to UW's implant program, giving researchers targeting brain and spinal injuries access to commercial-grade silicon engineering rather than lab-fabricated prototypes.
Second-order effects
- Neuralink and Kernel now compete against an incumbent whose business model is licensing chip designs rather than owning end products — a route that could let any university hospital team build implants on ARM cores, widening the field beyond vertically integrated startups like those covered in the DARPA-funded 64,000-electrode array effort.
Third-order effects
- If established semiconductor firms keep supplying implant silicon the way they supply phone makers, medical brain-computer interfaces could consolidate around licensed low-power architectures — the same structure that made ARM ubiquitous in mobile — with startups differentiating on software and clinical trials instead of chip design.
The trend: Brain-computer interface hardware is shifting from venture-backed startups toward established chip designers lending low-power architectures to academic medical programs.